Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16198312rdf:typepubmed:Citationlld:pubmed
pubmed-article:16198312lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C0014597lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C0384648lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C0007595lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:16198312lifeskim:mentionsumls-concept:C1704735lld:lifeskim
pubmed-article:16198312pubmed:issue2lld:pubmed
pubmed-article:16198312pubmed:dateCreated2005-10-14lld:pubmed
pubmed-article:16198312pubmed:abstractTextUpregulation of the T-cell derived cytokine interleukin (IL-17) was reported in the inflamed intestinal mucosa of patients with inflammatory bowel disorders. In this study, we analyzed the effect of IL-17 on human intestinal epithelial cell (HIEC) turnover and functions. Proliferation and apoptosis in response to IL-17 was monitored in HIEC (cell counts, [(3)H]thymidine incorporation method, and annexinV-PI-apoptosis assay). Signalling pathways were analyzed by Western blots, electromobility shift assay, and immunofluorescence studies. IL-17 proved to be a potent inhibitor of HIEC proliferation without any pro-apoptotic/necrotic effect. The growth inhibitory effect of IL-17 was mediated via the p38 stress kinase. Consequently, the p38-SAPkinase-inhibitor SB203580 abrogated this anti-mitotic effect. In parallel, IL-17 provoked the degradation of IkappaBalpha, allowing nuclear translocation of the p65 NF-kappaB subunit and induction of the NF-kappaB-controlled genes IL-6 and -8. IL-17 potently blocks epithelial cell turnover while at the same time amplifying an inflammatory response in a positive feedback manner.lld:pubmed
pubmed-article:16198312pubmed:languageenglld:pubmed
pubmed-article:16198312pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:citationSubsetIMlld:pubmed
pubmed-article:16198312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16198312pubmed:statusMEDLINElld:pubmed
pubmed-article:16198312pubmed:monthNovlld:pubmed
pubmed-article:16198312pubmed:issn0006-291Xlld:pubmed
pubmed-article:16198312pubmed:authorpubmed-author:SchwartzSSlld:pubmed
pubmed-article:16198312pubmed:authorpubmed-author:BeaulieuJ FJFlld:pubmed
pubmed-article:16198312pubmed:authorpubmed-author:RuemmeleF MFMlld:pubmed
pubmed-article:16198312pubmed:issnTypePrintlld:pubmed
pubmed-article:16198312pubmed:day18lld:pubmed
pubmed-article:16198312pubmed:volume337lld:pubmed
pubmed-article:16198312pubmed:ownerNLMlld:pubmed
pubmed-article:16198312pubmed:authorsCompleteYlld:pubmed
pubmed-article:16198312pubmed:pagination505-9lld:pubmed
pubmed-article:16198312pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:meshHeadingpubmed-meshheading:16198312...lld:pubmed
pubmed-article:16198312pubmed:year2005lld:pubmed
pubmed-article:16198312pubmed:articleTitleInterleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth.lld:pubmed
pubmed-article:16198312pubmed:affiliationChildren's Hospital, Mucosal Immunology Laboratory, University of Bonn, Germany.lld:pubmed
pubmed-article:16198312pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16198312pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16198312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16198312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16198312lld:pubmed